Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling

被引：0

作者：

Vincent C. Pai

Chung-Chi Hsu

Tze-Sian Chan

Wen-Ying Liao

Chih-Pin Chuu

Wei-Yu Chen

Chi-Rong Li

Ching-Yu Lin

Shu-Pin Huang

Li-Tzong Chen

Kelvin K. Tsai

机构：

[1] Taipei Medical University,Graduate Institute of Clinical Medicine, College of Medicine

[2] Taipei Medical University,Division of Gastroenterology, Department of Internal Medicine, Laboratory of Advanced Molecular Therapeutics, Wan Fang Hospital

[3] National Health Research Institutes,National Institute of Cancer Research

[4] National Health Research Institutes,Institute of Cellular and System Medicine

[5] Taipei Medical University,Department of Pathology, Wan Fang Hospital

[6] Taichung Hospital Ministry of Health and Welfare,Department of Teaching and Research

[7] Kaohsiung Medical University Chung-Ho Memorial Hospital,Department of Urology

来源：

Oncogene | 2019年 / 38卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In the published version of this paper the author Shu-Pin Huang’s surname was incorrectly given as Hwang instead of Huang. This has now been corrected in the HTML and PDF versions of the paper.

引用

页码：1354 / 1354

共 50 条

[1] ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling
Vincent C. Pai
Chung-Chi Hsu
Tze-Sian Chan
Wen-Ying Liao
Chih-Pin Chuu
Wei-Yu Chen
Chi-Rong Li
Ching-Yu Lin
Shu-Pin Huang
Li-Tzong Chen
Kelvin K. Tsai
[J]. Oncogene, 2019, 38 : 1340 - 1353
[2] ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling (vol 38, pg 1340, 2018)
Pai, Vincent C.
Hsu, Chung-Chi
Chan, Tze-Sian
Liao, Wen-Ying
Chuu, Chih-Pin
Chen, Wei-Yu
Li, Chi-Rong
Lin, Ching-Yu
Huang, Shu-Pin
Chen, Li-Tzong
Tsai, Kelvin K.
[J]. ONCOGENE, 2019, 38 (08) : 1354 - 1354
[3] ASPM promotes prostate cancer tumorigenesis by bolstering cancer stemness through Wnt-Dvl-3-b-catenin signaling
Tsai, Kelvin K.
Pai, Vincent C.
Hsu, Chung-Chi
Chan, Tze-Sian
[J]. CANCER RESEARCH, 2018, 78 (13)
[4] ASPM Promotes the Progression of Anaplastic Thyroid Carcinomas by Regulating the Wnt/β-Catenin Signaling Pathway
Jiang, Liang
Zhang, Shuai
An, Ning
Chai, Guoqing
Ye, Changhong
[J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2022, 2022
[5] ASPM promotes hepatocellular carcinoma progression by activating Wnt/β-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation
Zhang, Haifeng
Yang, Xiaobei
Zhu, Lili
Li, Zhihui
Zuo, Peipei
Wang, Peng
Feng, Jingyu
Mi, Yang
Zhang, Chengjuan
Xu, Yan
Jin, Ge
Zhang, Jianying
Ye, Hua
[J]. FEBS OPEN BIO, 2021, 11 (10): : 2784 - 2799
[6] WDR1 promotes prostate cancer progression through Wnt/β-catenin signaling
Cheng, Jinfeng
Huo, Dan
Zhang, Zhonghua
Zhang, Jianqing
Dong, Bizhen
Liu, Zhen
Zhou, Zhi
Lu, Yanjun
[J]. MEDICAL ONCOLOGY, 2024, 41 (06)
[7] ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression
Cheng, Li-Hsin
Hsu, Chung-Chi
Tsai, Hung-Wen
Liao, Wen-Ying
Yang, Pei-Ming
Liao, Tai-Yan
Hsieh, Hsiao-Yen
Chan, Tze-Sian
Tsai, Kelvin K.
[J]. CANCER RESEARCH, 2023, 83 (06) : 830 - 844
[8] FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling
Yin, Haofan
Gao, Tianxiao
Xie, Jinye
Huang, Zhijian
Zhang, Xiaoyan
Yang, Fengyu
Qi, Weiwei
Yang, Zhonghan
Zhou, Ti
Gao, Guoquan
Yang, Xia
[J]. MOLECULAR ONCOLOGY, 2021, 15 (12) : 3490 - 3512
[9] KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway
Zhang, Wei
Ruan, Xianhui
Li, Yaoshuang
Zhi, Jingtai
Hu, Linfei
Hou, Xiukun
Shi, Xianle
Wang, Xin
Wang, Jinpeng
Ma, Weike
Gu, Pengfei
Zheng, Xiangqian
Gao, Ming
[J]. THERANOSTICS, 2022, 12 (04): : 1500 - 1517
[10] SIRT6 Promotes the Progression of Prostate Cancer via Regulating the Wnt/β-Catenin Signaling Pathway
Zhang, Xian
Chen, Rong
Song, Li-De
Zhu, Ling-Fei
Zhan, Jian-Fei
[J]. JOURNAL OF ONCOLOGY, 2022, 2022

← 1 2 3 4 5 →